The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.MJ Olek...
Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, affecting ~2.5 million people worldwide. Currently, most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs, but these drugs are unable to halt or reverse the diseas...
Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment. Numerous large-scale clinical trials in...
Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment. Numerous large-scale clinical trials in...
Interferon-β treatment for multiple sclerosis Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-尾, approved for use in 1993, was the first ... RA Bermel,RA Rudick - 《Neurotherapeutics》 被引量: 109发表: 2007年 Short-term treatment...
The statement in the Dykes article that appears to have precipitated the confusion should be clarified.It is true, as Dykes said, that "50% of children and 65% to 75% of adults benefited from the effects of the drug." These percentages referred, however, to patients with spasticity caused...
摘要:Multiplesclerosisisthemostcommondisablingneurologicaldiseaseinyoungadults.Recentadvancesinunderstandingtheunderlyingmechanismsandthedevelopmentofnewtherapieshaveincreasedhopefordoctorsandtheirpatients.Newtherapiesareavailableandmanyotheragentsareun
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) may not be receiving optimal treatment.
Objective Sexual dysfunction in multiple sclerosis (MS) is a significant, but often underestimated and overlooked suffering. Interventions to treat sexual dysfunction in MS are rare. The relation between sexual dysfunction in MS and psychological as well as neuropsychological aspects is evident. However,...
Progress in biofeedback conditioning for fecal incontinence Medical problems associated with incontinence included irritable bowel syndrome, diabetes, rectal prolopse, multiple sclerosis, scleroderma, and stroke. Patients were taught to develop reflex transient contraction of the external sphincter in ... ...